Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Oculo-auriculo-vertebral spectrum, also termed Craniofacial Microsomia, is an autosomal dominant disorder characterized by variable hemifacial hypoplasia, microtia, mandibular hypoplasia, ocular defects, and vertebral anomalies. MYT1, encoding the myelin transcription factor 1, was first implicated as the causative gene via whole-exome sequencing in two sporadic cases harboring de novo truncating and missense variants (two probands) (PMID:27358179).
Subsequent studies have identified one additional de novo c.323C>T (p.Ser108Leu) variant in a Brazilian cohort (PMID:28612832), two novel variants in two unrelated individuals from a 128-trio study (PMID:32871052), and a recurrent SNV in five unrelated patients (PMID:33880880), bringing the total to ten unrelated probands.
The allelic spectrum comprises five distinct missense changes (p.Ser108Leu, p.Ser105Leu, p.Gly927Glu, p.Pro78Thr and the recurrent SNV) and one truncating allele (p.Arg9Ter). The exemplar variant c.323C>T (p.Ser108Leu) disrupts the repression of retinoic acid receptor genes, confirming its functional impact (PMID:28612832).
Inheritance is autosomal dominant, with de novo occurrence documented in multiple probands; no extended familial segregation has yet been reported.
Functional assays demonstrate that morpholino knockdown of zebrafish myt1a produces craniofacial cartilage defects mirroring human phenotypes (PMID:27358179), and cell culture overexpression shows that wild-type MYT1 downregulates RARA, RARB, and RARG, a function abrogated by pathogenic variants (PMID:27358179; PMID:28612832).
Collectively, multiple unrelated cases, consistent autosomal dominant de novo inheritance, and concordant functional disruption of retinoic acid signaling support a Strong gene–disease association for MYT1 in craniofacial microsomia. MYT1 should be included in diagnostic panels for OAVS to guide clinical decision-making.
Gene–Disease AssociationStrongTen unrelated probands with de novo or rare heterozygous MYT1 variants and replicated functional data across multiple studies Genetic EvidenceStrongIdentification of heterozygous MYT1 variants in ten unrelated individuals, including four de novo alleles across independent cohorts Functional EvidenceModerateZebrafish morpholino knockdown phenocopies OAVS and cellular assays show loss of retinoic acid receptor repression by mutant MYT1 |